Document is current
Any future updates will be listed below
-
Authors
Gillion, Valentine https://orcid.org/0000-0002-3319-5233
Dahan, Karin
Scohy, Anaïs
Devresse, Arnaud
Godefroid, Nathalie
-
Funding
Funding for this research was provided by:
Alnylam Pharmaceuticals
- License Information
-
More Information
Article History
Received: 15 March 2022
Accepted: 3 August 2022
First Online: 20 August 2022
Declarations
:
: Arnaud Devresse and Nathalie Godefroid declare fees from Alnylam. Karin Dahan declares fees from Alnylam, Pfizer and Sobi. The other authors declare no conflict of interest.
: The analyses involved existing parameters in an anonymized database where the user cannot identify individuals. The local ethical principles for data collection were respected.
